THE NOVEL NOMOGRAM OF GLEASON SUM UPGRADE: POSSIBLE APPLICATION FOR THE ELIGIBLE CRITERIA OF LOW DOSE RATE BRACHYTHERAPY СтатьяBudäus L., Graefen M., Salomon G., Schlomm T., Steuber T., Haese A., Heinzer H., Huland H., Isbarn H., Chun F.K., Fisch M., Koellermann J., Sauter G., Lughezzani G., Sun M., Karakiewicz P.I.International Journal of Urology. Том 17. 2010. С. 862-868
THE PROSTATE CANCER GENE 3 (PCA3) URINE TEST IN MEN WITH PREVIOUS NEGATIVE BIOPSIES: DOES FREE-TO-TOTAL PROSTATE-SPECIFIC ANTIGEN RATIO INFLUENCE THE PERFORMANCE OF THE PCA3 SCORE IN PREDICTING POSITIVE BIOPSIES? СтатьяPloussard G., Bastien L., Abbou C.C., De La Taille A., Haese A., Huland H., Stenzl A., Feyerabend S., Van Poppel H., Marberger M., Remzi M., Tinzl M., Mulders P.F.A., Stillebroer A.B., Van Gils M.P.M.Q., Schalken J.A.BJU International. Том 106. 2010. С. 1143-1147
DIFFERENCES IN BIOPSY FEATURES BETWEEN PROSTATE CANCERS LOCATED IN THE TRANSITION AND PERIPHERAL ZONE СтатьяErbersdobler A., Graefen M., Jaekel T., Haese A., Huland H., Hammerer P.G., Augustin H.BJU International. Том 91. 2003. С. 477-481
